# SUPERNUS PHARMACEUTICALS, INC. (SUPN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from SUPERNUS PHARMACEUTICALS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/SUPN/mda/fy2025/): filed 2026-03-02; accession 0001356576-26-000011 (https://www.sec.gov/Archives/edgar/data/1356576/000135657626000011/supn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/SUPN/mda/fy2024/): filed 2025-02-25; accession 0001356576-25-000017 (https://www.sec.gov/Archives/edgar/data/1356576/000135657625000017/supn-20241231.htm)
- [FY 2023 MD&A](/company/SUPN/mda/fy2023/): filed 2024-02-27; accession 0001356576-24-000013 (https://www.sec.gov/Archives/edgar/data/1356576/000135657624000013/supn-20231231.htm)
- [FY 2022 MD&A](/company/SUPN/mda/fy2022/): filed 2023-03-09; accession 0001356576-23-000016 (https://www.sec.gov/Archives/edgar/data/1356576/000135657623000016/supn-20221231.htm)
- [FY 2021 MD&A](/company/SUPN/mda/fy2021/): filed 2022-04-13; accession 0001356576-22-000025 (https://www.sec.gov/Archives/edgar/data/1356576/000135657622000025/supn-20211231.htm)

Back to /company/SUPN/